ASCRS 2020: Evolution of an administration technique for DEXYCU

Article

Ophthalmology Times' David Hutton speaks with Michael Saidel, MD, a cornea and cataract specialist, on his presentation regarding "Evolution of an administration technique for DEXYCU (dexamethasone intraocular suspension) 9%" during the 2020 ASCRS virtual meeting.
 

See more ASCRS coverage here 

Recent Videos
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.